XENE Stock Summary and Trading Ideas (Xenon Pharmaceuticals - Common Shares | NASDAQ:XENE)

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Xenon Pharmaceuticals - Common Shares trades on the NASDAQ stock market under the symbol XENE.

As of December 18, 2025, XENE stock price climbed to $43.23 with 673,908 million shares trading.

XENE has a beta of 0.90, meaning it tends to be less sensitive to market movements. XENE has a correlation of 0.14 to the broad based SPY ETF.

XENE has a market cap of $3.33 billion. This is considered a Mid Cap stock.

In the last 3 years, XENE traded as high as $50.99 and as low as $26.74.

The top ETF exchange traded funds that XENE belongs to (by Net Assets): IWM, IWO, IBB, VTWO, SPDW.

XENE has underperformed the market in the last year with a price return of +4.7% while the SPY ETF gained +13.1%. However, in the short term, XENE had mixed performance relative to the market. It has outperformed in the last 3 months, returning +17.8% vs +2.9% return in SPY. But in the last 2 weeks, XENE shares have been beat by the market, returning -2.4% compared to an SPY return of -1.1%.

XENE support price is $42.07 and resistance is $43.95 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XENE shares will trade within this expected range on the day.